IPH5401 (Anti-C5aR) in Combination With Durvalumab in Patients With Advanced Solid Tumors
about
IPH5401 (Anti-C5aR) in Combination With Durvalumab in Patients With Advanced Solid Tumors
description
clinical trial
@en
klinisch onderzoek
@nl
name
IPH5401 (Anti-C5aR) in Combination With Durvalumab in Patients With Advanced Solid Tumors
@en
type
label
IPH5401 (Anti-C5aR) in Combination With Durvalumab in Patients With Advanced Solid Tumors
@en
prefLabel
IPH5401 (Anti-C5aR) in Combination With Durvalumab in Patients With Advanced Solid Tumors
@en
P1476
A Phase I Study of the Anti-C5 ...... Selected Advanced Solid Tumors
@en
P1813
STELLAR-001
@en
P3098
NCT03665129
P4844
P580
2018-09-07T00:00:00Z
P582
2021-06-01T00:00:00Z